CWM
CPRX

CIBC World Markets’s Catalyst Pharmaceutical CPRX Stock Holding History

CIBC World Markets’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$310K Sell
14,265
-10,809
-43% -$255K ﹤0.01% 1089
2025
Q1 		$608K Buy
25,074
+14,611
+140% +$329K ﹤0.01% 910
2024
Q4 		$218K Buy
+10,463
New +$225K ﹤0.01% 1089

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

CIBC World Markets's CPRX Position: Q2 2025 in Review

CIBC World Markets reduced its Catalyst Pharmaceutical (CPRX) stake by 43% in Q2 2025, selling an estimated $255K and leaving 14,265 shares worth $310K. The position accounts for ﹤0.01% of the portfolio, ranked #1089.

CIBC World Markets first reported a position in CPRX in Q4 2024 and has held it in 3 quarters since. The position peaked at $608K in Q1 2025. 365 funds tracked by Wall St. Rank hold CPRX as of Q2 2025.

  • CIBC World Markets held 14,265 shares of Catalyst Pharmaceutical worth $310K as of Q2 2025.
  • CIBC World Markets sold 10,809 Catalyst Pharmaceutical shares in Q2 2025, an estimated $255K.
  • Catalyst Pharmaceutical made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1089 holding.
  • CIBC World Markets first reported a position in Catalyst Pharmaceutical in Q4 2024 and has held it in 3 quarters since.
  • CIBC World Markets's Catalyst Pharmaceutical position peaked at $608K in Q1 2025.
  • 365 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.